MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-06-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/9/6/e002029.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846173846064857088 |
|---|---|
| author | Yi Xiao Jianfeng Zhou Wei Zhang Jin Wang Li Yang Na Wang Liang Huang Jue Wang Liting Chen Min Xiao Jiachen Wang Zhen Shang Jinhuan Xu Weigang Li Yuqi Guan Kefeng Shen Meilan Zhang Qinlu Li Cheng He |
| author_facet | Yi Xiao Jianfeng Zhou Wei Zhang Jin Wang Li Yang Na Wang Liang Huang Jue Wang Liting Chen Min Xiao Jiachen Wang Zhen Shang Jinhuan Xu Weigang Li Yuqi Guan Kefeng Shen Meilan Zhang Qinlu Li Cheng He |
| author_sort | Yi Xiao |
| collection | DOAJ |
| format | Article |
| id | doaj-art-bae5ee095bbc4fcbb0c1c3b1fdc16eb7 |
| institution | Kabale University |
| issn | 2051-1426 |
| language | English |
| publishDate | 2021-06-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj-art-bae5ee095bbc4fcbb0c1c3b1fdc16eb72024-11-08T10:25:10ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-06-019610.1136/jitc-2020-002029MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapyYi Xiao0Jianfeng Zhou1Wei Zhang2Jin Wang3Li Yang4Na Wang5Liang Huang6Jue Wang7Liting Chen8Min Xiao9Jiachen Wang10Zhen Shang11Jinhuan Xu12Weigang Li13Yuqi Guan14Kefeng Shen15Meilan Zhang16Qinlu Li17Cheng He182 National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Central South University, Changsha, Hunan, ChinaDepartment of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, ChinaShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China1 Department of Anesthesiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China3 Department of Obstetrics, Norinco General Hospital, Xi`an, ChinaDepartment of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaDepartment of Breast Disease, The First Affiliated Hospital With Nanjing Medical University, Nanjing, Jiangsu, ChinaDepartment of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaDepartment of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, ChinaDepartment of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, ChinaDepartment of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, ChinaDepartment of Orthopedics, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, ChinaDepartment of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, ChinaDepartment of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, ChinaDepartment of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, ChinaDepartment of Haematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Chinapostdoctoral researcherhttps://jitc.bmj.com/content/9/6/e002029.full |
| spellingShingle | Yi Xiao Jianfeng Zhou Wei Zhang Jin Wang Li Yang Na Wang Liang Huang Jue Wang Liting Chen Min Xiao Jiachen Wang Zhen Shang Jinhuan Xu Weigang Li Yuqi Guan Kefeng Shen Meilan Zhang Qinlu Li Cheng He MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy Journal for ImmunoTherapy of Cancer |
| title | MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy |
| title_full | MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy |
| title_fullStr | MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy |
| title_full_unstemmed | MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy |
| title_short | MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy |
| title_sort | myc bcl2 bcl6 triple hit and tp53 deletion in a case of high grade b cell lymphoma receiving car t cell immunotherapy |
| url | https://jitc.bmj.com/content/9/6/e002029.full |
| work_keys_str_mv | AT yixiao mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT jianfengzhou mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT weizhang mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT jinwang mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT liyang mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT nawang mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT lianghuang mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT juewang mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT litingchen mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT minxiao mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT jiachenwang mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT zhenshang mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT jinhuanxu mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT weigangli mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT yuqiguan mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT kefengshen mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT meilanzhang mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT qinluli mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT chenghe mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy |